Microvascular Perfusion Imaging in Alzheimer's Disease

Area of Science:

• Neurology
• Medical Imaging
• Neuroscience

Background:

• Alzheimer's disease (AD) is a leading cause of dementia, characterized by amyloid-beta plaques and neurofibrillary tangles.
• Current diagnostic methods for AD, like amyloid and tau detection, are often invasive and costly.
• Standard brain imaging (MRI, CT) has limitations in accurately diagnosing AD and understanding its progression.

Purpose of the Study:

• To review current knowledge on microvascular perfusion imaging modalities for Alzheimer's disease.
• To highlight the application of these novel imaging techniques in understanding AD pathogenesis.
• To discuss the advantages of advanced imaging over traditional methods for AD diagnosis and research.

Main Methods:

• Review of existing literature on microvascular perfusion imaging in AD.
• Summary of various imaging modalities including MRI, CT, PET, SPECT, and TCD.
• Inclusion of retinal microvascular imaging techniques like OCT and computer-assisted evaluations.

Main Results:

• Novel imaging modalities can accurately visualize changes in brain blood flow and metabolism.
• These techniques provide insights into the cerebro-microvascular pathologies associated with AD.
• Emerging methods offer potential for improved diagnostic accuracy and accessibility compared to current approaches.

Conclusions:

• Microvascular perfusion imaging holds significant promise for advancing Alzheimer's disease research and diagnosis.
• These techniques can offer a more comprehensive understanding of AD's impact on brain vasculature.
• Further research and clinical application of these modalities are warranted for improved patient outcomes.